On September, 28th, at 11:00 am, we will hold a webinar on the "Rules of granting subsidies to implement the projects on drug development under the "Pharma 2020" Federal Target Program”. Register to the webinar The webinar is devoted...
On November 8-10th, IPHARMA will take a part in the "Clinical trials in Russia" Adam Smith Forum which is the main event of the year in the clinical trials field. As in previous years, IPHARMA has become a sponsor of this event and will report...
On September 12, 2016, IPHARMA was authorized by the Ministry of Health of the Russian Federation to conduct the Phase IIa clinical trial of the medicinal product VM-1011. Protocol № HBV-VM1011-02 «A partially-blind randomized comparative pilot clinical...
Since September 28th, IPHARMA will continue to hold a series of webinars in order to provide information to the vast media audience on variousaspects of clinical trials conduct. The company has an extensive experience in conducting trainings for the staff...
In August 2016, IPHARMA LLC was authorized by the Ministry of Healthcare of the Russian Federation to conduct the Phase I clinical trial of medicinal product ИД 4025. Protocol № HCV-ИД4025-04 «Double-blind randomized placebo-controlled study to evaluate...
IPHARMA company celebrated 4th Birthday on September 8. Traditional picnic was on the territory of Technopark Skolkovo. We had a good time in a friendly and fun atmosphere by the lake. Our regular guest Big Jazz Orchestra performed the hits of The Beatles and...